Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Nayak Abhay U 2. Date of Event Requiring Statement (Month/Day/Year) 06/15/2026 3. Issuer Name and Ticker or Trading Symbol Zoetis Inc. [ZTS] (Last) (First) (Middle) C/O ZOETIS INC., 10 SYLVAN WAY 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Executive Vice President 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) PARSIPPANY, NJ 07054 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) No securities beneficially held 0 D(1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(2)	(3)	(4)	Common Stock	1,122.8284	(5)	D
Restricted Stock Unit(2)	(6)	(4)	Common Stock	1,902.1798	(5)	D
Restricted Stock Unit(2)	(7)	(4)	Common Stock	625.6906	(5)	D
Restricted Stock Unit(2)	(8)	(4)	Common Stock	253.0883	(5)	D
Stock Option(9)	(10)	(11)	Common Stock	4,423	$129.13	D
Stock Option(9)	(12)	(11)	Common Stock	3,590	$156.64	D
Stock Option(9)	(13)	(11)	Common Stock	2,830	$196.14	D
Stock Option(9)	(14)	(11)	Common Stock	3,314	$162.07	D
Stock Option(15)	(16)	(11)	Common Stock	8,106	(17)	D
Phantom Stock Unit(18)	(18)	(18)	Common Stock	1,508.7729	(19)	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Nayak Abhay U C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY, NJ 07054			Executive Vice President

Signatures

/s/ Brenda Santuccio, as Attorney-in-Fact		06/17/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The reporting person was a Section 16 officer of Zoetis Inc., in his capacity as Executive Vice President, from January 1, 2020 to October 31, 2022, and as a result filed a Form 3 on January 8, 2020, and filed his last Form 4 on October 11, 2022. The securities reported as beneficially owned in this Form 3 reflect unreported transactions that occurred between October 11, 2022 and June 15, 2026, the date on which the reporting person again became a Section 16 officer for Zoetis Inc.
(2)	Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
(3)	One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
(4)	Not applicable.
(5)	Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
(6)	One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, January 30, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
(7)	One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
(8)	One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
(9)	Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
(10)	One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.
(11)	Each option expires on the tenth anniversary of the date of grant.
(12)	One-third of each option vests on the first, second and third anniversaries of the date of grant, February 19, 2025.
(13)	One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.
(14)	One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.
(15)	Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
(16)	Each option vested on the third anniversary of the date of grant.
(17)	1,147 options granted February 12, 2019 at an exercise price of $87.51 per option; 1,658 options granted February 11, 2020 at an exercise price of $144.03 per option; 2,478 options granted February 10, 2021 at an exercise price of $160.62 per option; and 2,823 options granted February 8, 2022 at an exercise price of $201.30 per option.
(18)	These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
(19)	Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.